An update on respiratory syncytial virus epidemiology: A developed country perspective

Respiratory Medicine

Volumn 96, Issue SUPPL. 2, 2002, Pages

  Law, B J ^a   Carbonell Estrany, X ^b,d   Simoes, E A F ^c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HOSPITAL CLÍNIC   (Spain)

^c Children's Hospital Colorado   (United States)

^d NONE   (Spain)

Author keywords

Epidemiology; Lower respiratory tract infection; Palivizumab; Prematurity; Prophylaxis; Respiratory syncytial virus

Indexed keywords

ARTIFICIAL VENTILATION; ATOPY; BELGIUM; BREAST FEEDING; CANADA; CHRONIC LUNG DISEASE; CONGENITAL HEART DISEASE; CROWDING; DEVELOPED COUNTRY; DISEASE SEVERITY; ENVIRONMENT; HEALTH EDUCATION; HEALTH SURVEY; HOSPITALIZATION; HUMAN; INTENSIVE CARE; ITALY; MORBIDITY; MORTALITY; NETHERLANDS; PASSIVE SMOKING; POVERTY; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; SEASONAL VARIATION; SPAIN; UNITED KINGDOM; UNITED STATES; VIRUS INFECTION; ARTICLE; EUROPE; INCIDENCE; INFANT; JAPAN; NEWBORN; SEASON; STATISTICS;

CANADA; DEVELOPED COUNTRIES; EUROPE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; JAPAN; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RISK FACTORS; SEASONS; UNITED STATES;

EID: 0036549469     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2002.1294     Document Type: Article

References (29)

1. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986; 140: 543-546.
2. Ducoffre G, Cauchi P, Hendrickx E. Respiratory syncytial virus epidemiology in Belgium in 1998, 1999 and 2000. Abstract presented at the 5th World Congress of Perinatal Medicine, 23-27 September, 2001, Barcelona, Spain.
3. Carbonell-Estrany X, Quero J, and the IRIS Study Group. RSV hospitalization rates in premature infants born over two consecutive seasons. Pediatr Infect Dis J 2001; 20: 874-879.
4. Cherian T, Simoes EA, Steinhoff MC, et al. Bronchiolitis in tropical south India. Am J Dis Child 1990; 144: 1026-1030.
5. Cunningham CK, McMillan JA, Gross SJ. Rehospitalization for respiratory illness in infants of less than 32 weeks' gestation. Pediatrics 1991; 88: 527-532.
6. Wang EEL, Law BJ, Stephens D, and other members of PICNIC. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1995; 126: 212-219.
7. WHO Bulletin OMS: 1995; Chapters 2 and 3 (Supplement): 7.
8. Brandenburg AH, Jeannet PY, Steensel-Moll HA, et al. Local variability in respiratory syncytial virus disease severity. Arch Dis Child 1997; 77: 410-414.
9. Behrendt CE, Decker MD, Burch DJ, Watson PH. International variation in the management of infants hospitalized with respiratory syncytial virus. International RSV Study Group. Eur J Pediatr 1998; 157: 215-220.
10. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998; 102: 531-537.
11. Groothuis, JR, Simoes EAF, Levin MJ, et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. N Engl J Med 1993; 329: 1524-1530.
12. Stevens TP, Sinkin RA, Hall CB, Maniscalco WM, McConnochie KM. Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier. Arch Pediatr Adolesc Med 2000; 154: 55-61.
13. Navas L, Wang E, de Carvalho V, Robinson J. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. J Pediatr 1992; 121: 348-354.
14. Meert K, Heidermann S, Abella B, Saeniak A. Does prematurity alter the course of respiratory syncytial virus infection? Crit Care Med 1990; 18: 1357-1359.
15. Simoes EAF, Rieger CHL. RSV infection in developed and developing countries. Infect Med 1999; 16: S11-S17.
16. Arnold SR, Wang EE, Law BJ, et al. Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: A review of the PICNIC RSV database. Pediatr Infect Dis J 1999; 18: 866-869.
17. Rljksinstituut voor Volksgezondheld en Milieu (National Institute of Public Health and the Environment) Infectieziekten Surveillance Informatie Systeem. Available at: http://www.isis.rivm.nl. Accessed December 5, 2001.
18. Rietveld E, Huysman WA, Steyerberg EW, Polder J, de Groot R, Moll HA. Variability of the incidence of hospitalization caused by infection with Respiratory Syncytial Virus (RSV). Abstract presented at European Society for Paediatric Infectious Diseases, Istanbul, Turkey, March 26-28, 2001.
19. Clark SJ, Beresford MW, Subhedar, NV, Shaw, NJ. Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort. Arch Dis Child 2000; 83: 313-316.
20. Thomas M, Bedford-Russell A, Sharland M. Hospitalization for RSV infection in ex-preterm infants - implications for use of RSV immune globulin. Arch Dis Child 2000; 83: 122-127.
21. Wang EEL, Law BJ, Robinson JL, et al. PICNIC (Pediatric Investigators Collaborative Network on Infections in Canada) study of the role of age and respiratory syncytial virus neutralizing antibody on respiratory syncytial virus illness in patients with underlying heart or lung disease. Pediatrics 1997; 99: e9.
22. Greenough A, Cox S, Alexander J, et al. Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection. Arch Dis Child 2001; 85:463-468.
23. Lanari M, Giovannini M, Giuffré L, et al. Epidemiological survey on Italian infants hospitalized with lower respiratory tract infections: role of respiratory syncytial virus. Abstract presented at the 5th World Congress of Perinatal Medicine, 23-27 September 2001, Barcelona, Spain.
24. Chezzi C and the Investigators study group. Epidemiologic multicenter study on the incidence of RSV respiratory infections in early childhood in Italy - relationship with hospitalization. Abstract presented at the 5th World Congress of Perinatal Medicine, 23-27 September 2001, Barcelona, Spain.
25. Shay DK, Holman RC, Roosevelt GE, Clarke MJ, Anderson LJ. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J Infect Dis 2001; 183: 16-22.
26. Howard TS, Hoffman LH, Stang PE, Simoes EA. Respiratory syncytial virus pneumonia in the hospital setting: length of stay, charges, and mortality. J Pediatr 2000; 137: 227-232.
27. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999; 282: 1440-1446.
28. Boyce TG, Mellen BG, Mitchel EF, et al. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J Pediatr 2000; 137: 865-870.
29. Kaneko M, Watanabe J, Kuwahara M, et al. Impact of RSV infection as a cause of lower respiratory tract infection in children younger than 3 years of age in Japan. Abstract presented at the 5th World Congress of Perinatal Medicine, 23-27 September 2001, Barcelona, Spain.